Lyka Labs Limited (NSE:LYKALABS)
India · Delayed Price · Currency is INR 56.50
-0.57 (-1.00%)
Mar 10, 2026, 3:29 PM IST
Lyka Labs Market Cap
Lyka Labs has a market cap or net worth of 2.02 billion as of March 10, 2026. Its market cap has decreased by -53.34% in one year.
Market Cap
2.02B
Enterprise Value
2.32B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
56.50
Market Cap Chart
Since October 1, 2003, Lyka Labs's market cap has increased from 294.62M to 2.02B, an increase of 584.43%. That is a compound annual growth rate of 8.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 2.04B | -24.80% |
| Dec 31, 2025 | 2.71B | -51.91% |
| Dec 31, 2024 | 5.63B | 37.55% |
| Dec 29, 2023 | 4.09B | 10.05% |
| Dec 30, 2022 | 3.72B | -41.66% |
| Dec 31, 2021 | 6.38B | 617.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 632.30B |
| Anthem Biosciences | 372.46B |
| OneSource Specialty Pharma | 169.70B |
| Concord Biotech | 126.29B |
| Blue Jet Healthcare | 66.84B |
| Supriya Lifescience | 50.54B |
| Zota Health Care | 40.47B |
| Dishman Carbogen Amcis | 25.75B |